Clinical management of hypophosphatemic osteomalacia induced by adefovir and tenofovir: Insights from a case report

Yinhui He,Xin Huang,Yongjun Ye,Haiyan Xu
DOI: https://doi.org/10.1097/md.0000000000040746
IF: 1.6
2024-12-01
Medicine
Abstract:Hypophosphatemic rickets/osteomalacia is a group of rare chronic metabolic bone diseases characterized by low blood phosphate levels owing to genetic or acquired causes. In adults, it is known as osteomalacia and presents with fatigue, bone pain, multiple fractures, and limited mobility. [ 1 ] Drug-induced renal tubular damage, or Fanconi syndrome, is a common cause of acquired hypophosphatemic osteomalacia. Most cases of drug-induced hypophosphatemic osteomalacia are associated with a single medication. [ 2–4 ] This article reports a case of hypophosphatemic osteomalacia caused by sequential treatment with adefovir dipivoxil and tenofovir alafenamide, and summarizes its clinical management.
medicine, general & internal
What problem does this paper attempt to address?